News & Events
LIPINOVA™ SPM International Innovation Summit: A Collaboration with Solutex
Global Experts Gather to Explore the Science of "Resolution
On March 24, 2026, Nutrarex Biotech Co., Ltd. successfully hosted the "LIPINOVA™ SPM International Innovation Summit" at the GIS NTU Convention Center in Taipei. This landmark event was held in partnership with Solutex S.L., a global leader in Spanish Omega-3 science and manufacturing. The summit brought together prominent academic and industry experts to discuss the clinical mechanisms of Specialized Pro-Resolving Mediators (SPMs) and their emerging role in the global health market.
As Taiwan's first international conference centered on SPMs, the event attracted a wide range of health industry professionals, medical experts, and representatives from leading healthcare brands. The vibrant exchange of ideas highlighted the market's high level of interest in next-generation lipid science.
A Framework for SPM Science and Global Market Applications
The summit featured a lineup of world-renowned speakers, integrating multidisciplinary perspectives to provide a comprehensive overview of SPMs—from foundational scientific research to practical market applications.
Charles N. Serhan, PhD
(Professor, Harvard Medical School)
As the discoverer of SPMs and a pioneer in inflammation resolution research, Dr. Serhan shared the history and vision behind his work via a special video address to the Taiwan audience.
Xavier De La Rosa, PhD
A researcher at the forefront of translating SPM science into human applications, focusing on how SPMs function within human biological systems
Gustavo A. Higuera, PhD
(Senior Clinical Project Manager, Solutex S.L.)
Discussed the forward-looking scientific developments and future application directions for SPMs
Sonia Moreno Olaya
(Head of Global Marketing and Scientific Strategy, Solutex S.L.)
Shared the innovative journey of LIPINOVA™ SPM and its global commercial landscape
Cheng-Yu Wu, PhD (Nutrarex Biotech)
Provided an in-depth analysis of the practical applications and industrial opportunities for LIPINOVA™ SPM within the Taiwan market.
From "Inhibition" to "Resolution": Redefining Biological Regulatio
The core theme of the summit focused on a pivotal perspective: biological reactions are not inherently problematic; the key lies in whether the body can successfully "complete" the response. When the body is stimulated, it enters a highly active state as a necessary defense mechanism. However, true balance is achieved not by simply suppressing the reaction, but by ensuring the process reaches a full conclusion.
SPMs serve as the signaling molecules that guide this "conclusion," entering what is known as the Resolution Phase. Rather than inhibiting a response, SPMs signal the gradual shutdown of active pathways, facilitate the removal of cellular debris, and lead the system back to its original state of stability (homeostasis).
Under this scientific framework, LIPINOVA™ SPM represents more than just a product; it is a new understanding of lipid science—moving from single-action suppression back to supporting complete physiological mechanisms. This shift from chaos to balance is redefining the way we think about health management and product development.
Connecting with International Trends and Asian Market Opportunitie
LIPINOVA™ SPM was co-developed by Solutex and Dr. Charles Serhan of Harvard Medical School. By activating natural regulatory mechanisms to maintain internal stability at the source, this ingredient has gained significant industry attention and has been featured in numerous international scientific publications.
This summit was not only a scientific exchange but an upgrade in industrial vision. Through deep cooperation with Solutex and the participation of international experts, the Taiwan market is now directly connected to the pulse of global lipid science. This partnership provides our brand partners and industrial colleagues with new directions for product innovation and opportunities for differentiation
Other
